Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Beginning Cash Balance: 2013-2025

Historic Beginning Cash Balance for Phibro Animal Health (PAHC) over the last 13 years, with Sep 2025 value amounting to $68.0 million.

  • Phibro Animal Health's Beginning Cash Balance fell 3.65% to $68.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $51.8 million, marking a year-over-year increase of 20.12%. This contributed to the annual value of $70.6 million for FY2025, which is 71.05% up from last year.
  • Per Phibro Animal Health's latest filing, its Beginning Cash Balance stood at $68.0 million for Q3 2025, which was up 12.73% from $60.4 million recorded in Q2 2025.
  • Phibro Animal Health's Beginning Cash Balance's 5-year high stood at $76.3 million during Q4 2022, with a 5-year trough of $33.0 million in Q1 2024.
  • Moreover, its 3-year median value for Beginning Cash Balance was $51.8 million (2024), whereas its average is $53.7 million.
  • Per our database at Business Quant, Phibro Animal Health's Beginning Cash Balance crashed by 51.81% in 2024 and then spiked by 103.44% in 2025.
  • Phibro Animal Health's Beginning Cash Balance (Quarterly) stood at $41.2 million in 2021, then spiked by 85.26% to $76.3 million in 2022, then tumbled by 43.43% to $43.2 million in 2023, then increased by 20.12% to $51.8 million in 2024, then declined by 3.65% to $68.0 million in 2025.
  • Its Beginning Cash Balance was $68.0 million in Q3 2025, compared to $60.4 million in Q2 2025 and $67.1 million in Q1 2025.